Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Overall Safety and Tolerability Assessment The primary safety conclusion from the comprehensive trial program was unambiguous: AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo
Potential conflict of interest to note: Several of the study authors worked for the company who produced the product used in the study
No treatment typically needed
Schedule a consultation to explore how we can help
A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer
US$ 28.32
US$ 26.27
US$ 29.73
US$ 24.75
US$ 29.41
US$ 25.79
US$ 20.44
US$ 29.78
